Sectors
CPIX
Cumberland Pharmaceuticals Inc.
6.69
2 x 6.12
2 x 8.53
bid
ask
-
1.77
20.92%
2 @ 06:01 PM
6.60 -0.09 (1.35%)
| Ytd | 68.09% | |
| 1y | 91.69% |
6.60
day range
8.50
1.85
52 week range
9.28
| Open | 8.21 | Prev Close | 8.46 | Low | 6.60 | High | 8.50 | Mkt Cap | 100.24M |
| Vol | 190.35K | Avg Vol | 91.58K | EPS | -0.22 | P/E | N/A | Forward P/E | 16.07 |
| Beta | 0.22 | Short Ratio | 0.92 | Inst. Own | 14.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 7.14 | 200-d Avg | 4.69 | 1yr Est | 8.50 |
| Income Statement | |||
| Total Revenue | 166.46K | ||
| Revenues (USD) | 166.46K | ||
| Gross Profit | 166.46K | ||
| Operating Expenses | 3.33M | ||
| Research and Development Expense | 772.16K | ||
| Selling, General and Administrative Expense | 2.55M | ||
| Operating Income | -3.16M | ||
| Interest Expense | 724.00 | ||
| Income Tax Expense | 3.87K | ||
| Net Income | -4.28M | ||
| Net Income Common Stock | -4.28M | ||
| Net Income Common Stock (USD) | -4.28M | ||
| Consolidated Income | -4.27M | ||
| Net Income from Discontinued Operations | 1.17M | ||
| Net Income to Non-Controlling Interests | 1.95K | ||
| Earnings per Basic Share | -0.29 | ||
| Earnings per Basic Share (USD) | -0.29 | ||
| Earnings per Diluted Share | -0.29 | ||
| Earning Before Interest & Taxes (EBIT) | -4.27M | ||
| Earning Before Interest & Taxes (USD) | -4.27M | ||
| Weighted Average Shares | 14.98M | ||
| Weighted Average Shares Diluted | 14.98M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.86M | ||
| Cash and Equivalents (USD) | 3.86M | ||
| Trade and Non-Trade Receivables | 13.42M | ||
| Current Assets | 33.64M | ||
| Property, Plant & Equipment Net | 7.53M | ||
| Total Assets | 62.88M | ||
| Debt Current | 503.02K | ||
| Total Debt | 4.71M | ||
| Current Liabilities | 35.19M | ||
| Debt Non-Current | 4.21M | ||
| Total Liabilities | 45.77M | ||
| Accumulated Retained Earnings (Deficit) | -34.37M | ||
| Shareholders Equity | 17.44M | ||
| Shareholders Equity (USD) | 17.44M | ||
| Assets Non-Current | 29.24M | ||
| Total Debt (USD) | 4.71M | ||
| Goodwill and Intangible Assets | 43.80K | ||
| Inventory | 70.81K | ||
| Liabilities Non-Current | 10.58M | ||
| Trade and Non-Trade Payables | 19.55M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -1.01M | ||
| Net Cash Flow from Financing | -5.39M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.14M | ||
| Capital Expenditure | -1.78M | ||
| Issuance (Repayment) of Debt Securities | -5.24M | ||
| Net Cash Flow from Investing | -1.93M | ||
| Net Cash Flow from Operations | 168.74K | ||
| Share Based Compensation | 77.87K | ||